Follow-up study of patients with clinically suspected deep venous thrombosis and a normal venogram

Lactobacillus gasseri BNR17 Supplementation Reduces the Visceral Fat Accumulation and Waist Circumference in Obese Adults: A Randomized, Double-Blind, Placebo-Controlled Trial

Lactobacillus gasseri BNR17 is a probiotic strain isolated from human breast milk. Animal studies reported that BNR17 inhibited increases in body weight and adipose tissue weights. The purpose of this study was to evaluate the antiobesity effects of BNR17 in humans. In a randomized, double-blind, placebo-controlled trial, 90 volunteers aged 20-75 years with body mass index (BMI) from 25 to 35 kg/m² were randomized to receive a placebo, low-dose BNR (BNR-L, 10⁹ CFU/day), or high-dose BNR (BNR-H, 10¹⁰ CFU/day) for 12 weeks. Body weight, BMI, waist and hip circumferences, waist-to-hip ratio, abdominal adipose tissue areas, body fat mass, lean body mass, and biochemical parameters were assessed at the beginning and end of the trial. Visceral adipose tissue (VAT) was significantly decreased in the BNR-H group compared with the placebo group (P = .038). Difference of VAT areas of the BNR-H group compared with the placebo group after 12-week consumption of BNR17 was significant (-21.6 cm², P = .012). Waist circumferences were significantly decreased in both the BNR-L and BNL-H groups (P = .045 and .012, respectively) compared with the baseline values, but not in the placebo group. Biochemical parameters were not significantly different among the groups. These findings suggest that daily consumption of BNR17 may contribute to reduced visceral fat mass in obese adults.

Augmentation in Lower Extremity Sonography for the Detection of Deep Venous Thrombosis

OBJECTIVE

The purpose of our study was to evaluate the usefulness of venous flow augmentation with duplex sonography in the evaluation of deep venous thrombus of the lower extremities.

CONCLUSION

The augmentation component of the lower extremity sonogram rarely provides additional information in the diagnosis of deep venous thrombus. In our large series, no deep venous thromboses were discovered with augmentation. Factors such as the lack of usefulness and patient discomfort may justify removal of augmentation from the routine study. However, augmentation should still be applied as a diagnostic tool in difficult or uncertain cases.

A detailed analysis of equivocal duplex findings in patients with suspected deep venous thrombosis

OBJECTIVE

To analyze equivocal duplex findings in patients with clinically suspected deep venous thrombosis and thus to increase the diagnostic utility of color duplex sonography in this category of patients.

METHODS

Phlebography was requested in a series of 102 consecutive patients with inconclusive duplex findings. These patients were, according to the duplex findings only, subdivided into having low, intermediate, and high probability of deep venous thrombosis.

RESULTS

Phlebographywas attempted in 71 cases and successfully performed in 49. The remaining 53 patients were prospectively followed clinically for 6 months. Phlebography showed deep venous thrombosis in 1 of 63 patients in the group with low probability, 3 of 31 in the intermediate group, and all of the 8 patients with high probability. Twenty-two (31%) of the 71 attempted phlebographic examinations were nondiagnostic. None of the patients in the follow-up group had any thromboembolic complications.

CONCLUSIONS

Even if a duplex examination is equivocal, it is still possible to extract clinically useful information by categorizing the duplex results into subgroups with low, intermediate, and high probability of deep venous thrombosis. This can have implications for the diagnostic or therapeutic handling of these patients and thus can increase the utility of sonography in patients with inconclusive duplex findings.

Is it safe to withhold anticoagulation based on a single negative color duplex examination in patients with suspected deep venous thrombosis? A prospective 3-month follow-up study

The aim of this study was to evaluate prospectively the clinical short-term outcome of patients with suspected deep venous thrombosis (DVT) and negative duplex investigation and to assess whether it is clinically safe to withhold anticoagulant therapy on the basis of a single negative color duplex examination including the calf veins. The study included a consecutive series of patients with suspected DVT referred for color duplex examination over 1 year. Patients with negative duplex findings (n = 341) were followed up for 3 months clinically and/or by reviewing hospital charts and the official registry of health care and causes of death. In only 1 of the patients was DVT diagnosed following a negative duplex examination. This patient had accentuated symptoms and a thrombus in the peroneal vein was detected at subsequent phlebography. None of the other patients with a negative duplex finding developed signs of, or had treatment initiated for, DVT or pulmonary embolism during the 3-month period after the duplex investigation. Five patients died, but none of the deaths was related to thromboembolism. The results indicate that it is clinically safe to rely on a single negative color duplex examination in patients without any progressing symptoms from the affected limb.

Deep venous thrombosis: complete lower extremity venous US evaluation in patients without known risk factors--outcome study

PURPOSE

To determine the diagnostic value of venous ultrasonography (US) that includes examination of calf veins in symptomatic patients suspected of having deep venous thrombosis (DVT) of the lower extremities.

MATERIALS AND METHODS

A retrospective cohort study of the prevalence of DVT included 977 consecutive patients with possible DVT but without known risk factors for DVT. Color flow and compression US were performed. The outcome was the frequency of overlooked, clinically important DVT after negative initial results from bilateral venous US of above- and below-the-knee veins. Patient records (904 patients), mailed questionnaires (61 patients), and telephone contacts (12 patients) were used to establish a diagnosis of clinically relevant DVT.

RESULTS

The prevalence of DVT was 15% (142 of 977), with DVT in 15% (21 of 142) restricted to the below-the-knee veins. Follow-up (median, 34 months) in 835 patients with negative US findings showed one occurrence of venous thrombosis (superficial thrombophlebitis) during the first 3 months of follow-up. Three other cases of venous thrombosis occurred at 17, 18, and 48 months of follow-up but were believed not to be linked to the initial complaint. The incidence of overlooked DVT was 0% (95% CI, 0.0%, 0.4%).

CONCLUSION

In patients without risk factors for DVT, a negative venous US study can help exclude the presence of clinically important DVT if the examination includes careful evaluation of the calf veins.

Deep venous thrombosis: recent advances and optimal investigation with US

Compression US is the imaging procedure of choice for patients with clinically suspected DVT of the lower and upper extremities. Clinical trials have validated the safety of the approach of relying on two negative US studies obtained 1 week apart to safely exclude the diagnosis of DVT. In selected low-risk patients, the diagnosis of DVT may be excluded by a single negative US study. US has a role to play in the management of patients with suspected pulmonary embolism who have nondiagnostic pulmonary imaging studies.

Deep venous thrombosis and pulmonary embolism following cast immobilization of the lower extremity

It is generally accepted that venous thrombosis in the lower extremity predisposes to pulmonary embolism. A case of pulmonary embolism after cast immobilization of the lower extremity, as well as a review of thromboembolic disease is presented. A high level of vigilance and close follow-up of even simple cast treatment is necessary to avoid this complication.